2 February 2023

Last updated: Saturday 28 January 2023

Research Directory

After three years of Covid, risks to health remain

Novel oncology drugs approved in a year of change

Q4 2022 Stock Comment

Pharma should target fungal diseases, says WHO

Progressive increase in oncology drug approvals

New era for drug pricing in US

Checkpoint inhibitors are focus at ESMO

Biotech companies advised to conserve cash

Viable malaria vaccine moves a step closer

Antibody-drug conjugates come to the fore